Projected Price to Earnings: Neurocrine Biosciences Inc (NBIX)

Graphic logo of Neurocrine Biosciences (NBIX)

The growth of Neurocrine Biosciences (NBIX) relies on sales of movement disorder treatments and the development of new molecules. Fundamental success is based on the dominance of Ingrezza and FDA approvals. The company's forward P/E ratio on this GURU.Markets platform chart demonstrates a trend where 17.10 reflects the metric's baseline. Drug development is accelerating via AI, although final tests still require physician involvement.

Future Price to Earnings Multiple: Neurocrine Biosciences, Inc. (NBIX) for 07/04/2022 - 11/18/2026

Metric breakdowns and analytics for neurocrine.com (NBIX)

- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
Fundamental valuation:Neurocrine Corp
Brand item of Neurocrine Biosciences

For Neurocrine Biosciences (NBIX), this indicator determines the fair value of shares relative to projected earnings. The metric compares the current price with expected annual income to identify whether the asset is overvalued or undervalued. Analyzing the company's forward P/E ratio allows for an assessment of price correction risks. Low values confirm the resilience of a business supported by inelastic demand and the dominance of Ingrezza, making investments in the company more secure.

Main competitors

Forward P/E Multiple BIIB|Regencell (RGC) - Forward Price to Earnings Multiple|Future Price to Earnings axsome.com AXSM|Forward P/E Multiple ACADIA Pharmaceuticals ACAD|XENE - Future Price to Earnings|Market Cap to Projected Earnings Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Future Price to Earnings|CPRX (Catalyst Pharmaceuticals) - Future Price to Earnings|DNLI (denalitherapeutics.com) - Forward P/E Multiple|Price to Future Earnings Ratio HRMY (Harmony Biosciences Holdings, Inc.)|Forward P/E Multiple BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Future Price to Earnings Multiple|Forward P/E Multiple TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Price to Expected Earnings Ratio|anavex.com - Forward P/E Multiple|Future Price to Earnings Multiple CBLL (CeriBell, Inc.)|PRTA: Forward P/E Multiple|Price to Future Earnings Ratio ALEC|ANNX (Annexon Biosciences Inc.) - Forward P/E Multiple|omeros.com - Price to Expected Earnings Ratio|Future Price to Earnings Neurogene (NGNE)|Market Cap to Projected Earnings AC Immune SA|Forward P/E Multiple VYGR (voyagertherapeutics.com)|Forward P/E Multiple Neumora NMRA|Scilex Holding - Forward P/E Multiple|Projected Price to Earnings Ratio Tevogen Bio Inc.|Alpha Cognition (ACOG) - Future Price to Earnings|cogrx.com (CGTX) - Forward P/E Multiple|Future Price to Earnings Inhibikase Therapeutics|Cassava (SAVA) - Market Cap to Projected Earnings|Future Price to Earnings Assertio Therapeutics (ASRT)|Market Cap to Projected Earnings Coya|Vistagen - Projected Price to Earnings|Future Price to Earnings Multiple OVID|Acumen Pharmaceuticals Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio CervoMed Inc|ATHE: Forward P/E Multiple|Projected Price to Earnings Clene Nanomedicine|Future Price to Earnings PepGen Corp|Jupiter Neurosciences (JUNS) - Market Cap to Projected Earnings|Future Price to Earnings Relmada Therapeutics, Inc. (RLMD)|ANVS - Projected Price to Earnings Ratio|gracetx.com - Projected Price to Earnings|AIFF: Price to Future Earnings Ratio|Klotho Neurosciences - Forward P/E Multiple|NRSN (NeuroSense Therapeutics Ltd.) - Price to Future Earnings Ratio|Reviva Pharmaceuticals (RVPH) - Future Price to Earnings|MTVA (MetaVia Inc.) - Future Price to Earnings|Future Price to Earnings NeurAxis, Inc|Future Price to Earnings HSDT|Forward P/E Multiple PASG|Market Cap to Projected Earnings Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Projected Price to Earnings|Forward P/E Multiple Athira ATHA|Addex Therapeutics - Forward P/E Multiple|ALZN - Forward P/E Multiple|Cyclerion (CYCN) - Future Price to Earnings|Protagenic (PTIX) - Forward P/E Multiple|Future Price to Earnings Pasithea|Price to Future Earnings Ratio CRGT (Cortigent)|Future Price to Earnings Avenue Therapeutics (ATXI)|BCLI - Projected Price to Earnings Ratio|Forward P/E Multiple CARA (Cara Therapeutics Inc)|CHRO - Projected Price to Earnings|ELYM: Projected Price to Earnings|Market Cap to Projected Earnings Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Future Price to Earnings|Marinus - Future Price to Earnings Multiple|Future Price to Earnings NKGen Biotech Inc|NRBO: Future Price to Earnings Multiple|Projected Price to Earnings SAGE (Sage Therapeutics, Inc.)|Market Cap to Projected Earnings Neurotrope|Future Price to Earnings Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Projected Price to Earnings Ratio|WENA: Projected Price to Earnings|Future Price to Earnings Multiple CERE (Cerevel Therapeutics)